Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia

Scandinavian Journal of Gastroenterology

Volumn 43, Issue 5, 2008, Pages 604-608

  De Boer, Nanne K H ^a   Tuynman, Henriette ^b   Bloemena, Elisabeth ^a   Westerga, Johan ^b   Van Der Peet, Donald L ^a   Mulder, Chris J J ^a   Cuesta, Miquel A ^a   Meuwissen, Stephan G M ^a   Van Nieuwkerk, Carin M ^a   Van Bodegraven, Adriaan A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Azathioprine; Hepatotoxicity; Inflammatory bowel disease; Liver fibrosis; Nodular regenerative hyperplasia; Sinusoidal dilatation; Steatosis; Thiopurine

Indexed keywords

MERCAPTOPURINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CROHN DISEASE; FATTY LIVER; FEMALE; GASTROINTESTINAL SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER HYPERPLASIA; LIVER HYPERTROPHY; LIVER NODULE; LIVER REGENERATION; LIVER SINUSOID; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT REFERRAL; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; TISSUE SECTION;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BIOPSY, NEEDLE; FEMALE; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LIVER; MALE; MIDDLE AGED;

EID: 42149177883     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701800266     Document Type: Article

References (27)

1. Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Dig Liver Dis 2005;37:282-97.
2. de Jong DJ, Derijks LJ, Naber AH, Hooymans PM, Mulder CJ. Safety of thiopurines in the treatment of inflammatory bowel disease. Scand J Gastroenterol 2003;Suppl 239:69-72.
3. Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003;125:298-303.
4. Seiderer J, Zech CJ, Reinisch W, Lukas M, Diebold J, Wrba F, et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 2005;43:303-9.
5. Geller SA, Dubinsky MC, Poordad FF, Vasiliauskas EA, Cohen AH, Abreu MT, et al. Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol 2004;28:1204-11.
6. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006;44:7-14.
7. International Working Party.Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983-93.
8. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
9. Kleiner DE, Brent EM, van Natta M, Behling C, Contos MJ, Cumming OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.
10. Thomas CH. Ulceration of the colon with a much enlarged fatty liver. Transactions of the Pathology Society of Philadelphia 1873;4:87-8.
11. Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, et al. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol Clin Biol 2005;29:600-3.
12. Russmann S, Zimmermann A, Krähenbühl S, Kern B, Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:287-90.
13. Naber AH, van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991;12:94-9.
14. Buffet C, Cantarovitch M, Pelletier G, Fabre M, Martin E, Charpentier B, et al. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation. Nephrol Dial Transplant 1988;3:327-30.
15. Haboubi NY, ALi HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988;83:256-61.
16. Fonseca V, Havard CW. Portal hypertension secondary to azathioprine in myasthenia gravis. Postgrad Med J 1988;64:950-2.
17. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994;20:88-94.
18. Breen DP, Marinaki AM, Arenas M, Hayes PC. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl 2005;11:826-33.
19. Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007;56:1404-9.
20. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
21. Holtmann M, Schreiner O, Köhler H, Denzer U, Neurath M, Galle PR, et al. Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine. Dig Dis Sci 2003;48:1503-5.
22. Stoneham S, Lennard L, Coen P, Lilleyman J, Saha V. Venoocclusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia. Br J Haematol 2003;123:100-2.
23. Jacobi AM, Feist E, Rudolph B, Burmester GR. Sinusoidal dilatation: a rare side effect of azathioprine. Ann Rheum Dis 2004;63:1702-3.
24. Eade MN, Cooke WT, Brooke BN. Liver disease in ulcerative colitis. Lancet 1970;2:718.
25. Eade MN, Cooke WT, Williams JA. Liver disease in Crohn's disease. A study of 100 consecutive patients. Scand J Gastroenterol 1971;6:199-204.
26. Mattila J, Aitola P, Matikainen M. Liver lesions found at colectomy in ulcerative colitis: correlation between findings and biochemical parameters. J Clin Pathol 1994;47:1019-21.
27. Aitola P, Matikainen M, Aitola P. Hepatobiliary changes in patients with ulcerative colitis, with special reference to the effect of proctocolectomy. Scand J Gastroenterol 1998;33:113-7.